This is the authors' abstract. We don't add key points for this paper.
Our study underscores the importance of optimizing treatment strategies and considering the timing and integration of radiotherapy and immunotherapy to improve outcomes for patients with ES-SCLC, particularly those at risk of or presenting with BMs.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Zeng et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: